Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

'Effect of metformin on breast cancer metabolism'


Simon LordSimon Lord is a Senior Clinical Researcher in Experimental Cancer Therapeutics based in the Early Phase Cancer Trials Unit and consultant in medical oncology at the Oxford Cancer Centre. He undertook clinical training in Southampton, Leeds and Oxford and in 2010 was awarded a CRUK Clinical Research Fellowship with Professor Adrian Harris at the Weatherall Institute of Molecular Medicine in Oxford, subsequently earning a DPhil for his work investigating therapeutic approaches to target mitochondria in breast cancer.

His clinical interests focus on development of new drugs to treat breast cancer and he is principal and chief investigator on a number of clinical trials of novel therapies. He has an active ‘laboratory to clinic’ research programme which uses genetic and metabolic approaches using tumour cells grown directly from patient samples to characterise the behaviour of breast cancers that arise in patients with obesity and diabetes.


Chair: Professor Ashok Handa

All members of the University and NHS clinical staff are welcome.